
Migject Plus 40mg/10mg Injection
Marketer
Cista Medicorp
Salt Composition
Propranolol (40mg) + Flunarizine (10mg)
Overview Migject Plus 40mg/10mg Injection
CelerMig 40mg/10mg injection combines two active ingredients to prevent migraine episodes. It's not intended for treating already-occurring migraines. Consistent daily use, ideally at bedtime, is crucial. Discontinuing this medication requires prior physician consultation. Adopting a healthier lifestyle, including stress reduction, smoking cessation, and a balanced diet, can enhance its efficacy. Drowsiness is a potential side effect; avoid driving or tasks demanding concentration afterward. Frequently reported side effects include weight increase, bradycardia, fatigue, depressive symptoms, somnolence, and peripheral vasoconstriction.
Uses of Migject Plus 40mg/10mg Injection
Migraine prevention strategies
Major Benefits of Migject Plus 40mg/10mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Migject Plus 40mg/10mg Injection:
- Weight gain
- Slow heart rate
- Tiredness
- Depression
- Drowsiness
- Abnormal dreams
- Cold extremities
How to use Migject Plus 40mg/10mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Migject Plus 40mg/10mg Injection works:
Migject Plus, a 40mg/10mg injectable solution, combines propranolol (a beta-blocker) and flunarizine (a calcium channel blocker) to prevent migraine attacks. This dual action stabilizes hyperactive nerve cells, raising the threshold for migraine initiation. Furthermore, the medication suppresses cortical spreading depression, the electrical brain activity linked to migraine pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while using Migject Plus 40mg/10mg Injection.
PregnancyCONSULT YOUR DOCTOR
Use of Migject Plus 40mg/10mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Migject Plus 40mg/10mg Injection with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
The administration of Migject Plus 40mg/10mg Injection may induce adverse reactions impacting driving aptitude. Potential side effects include blurred vision, hallucinations, lethargy, cognitive impairment, vertigo, and somnolence, all of which could compromise safe driving.
KidneySAFE IF PRESCRIBED
The use of Migject Plus 40mg/10mg Injection in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary, but physician consultation is advised.
LiverCAUTION
The injectable medication, Migject Plus 40mg/10mg, requires careful administration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended. Routine blood pressure checks are advised to guide dosage alterations.
What if you forget to take Migject Plus 40mg/10mg Injection :
NA
Facts to Know About Migject Plus 40mg/10mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
